You've just added:

Home / News

News + Media

September 13, 2016

Lasker Award Honors William Kaelin, MD, Harrington Scientific Advisory Board Member

The Lasker Awards, among the most respected prizes in medicine, will go to six researchers who made major discoveries in physiology and virology, and to a scientist who has tirelessly promoted science education, the Albert and Mary Lasker Foundation announced on Tuesday. The awards, honoring basic medical research, clinical... Continue Reading

August 15, 2016

Harrington Discovery Institute Receives Grant from Burton D. Morgan Foundation

Cleveland – The Trustees of the Burton D. Morgan Foundation in Hudson Ohio have awarded a grant of $200,000 to the Harrington Discovery Institute at University Hospitals in Cleveland, Ohio to support the Institute’s Innovation Support Center (ISC) and its mission of mentoring physician-scientists to advance novel... Continue Reading

June 13, 2016

Arix Bioscience Supports OptiKira, a Company Developing Drugs to Fight Blindness

LONDON AND CLEVELAND, OHIO, JUNE 13, 2016: Arix Bioscience Limited (Arix Bioscience), a global healthcare and life science company supporting medical innovation, announced today it has provided development capital to OptiKira, LLC (OptiKira), an early stage company developing drugs to help prevent blindness. Extensive research... Continue Reading

June 06, 2016

Partners Play a Key Role in the Battle Against Brain Diseases

When the Lauder family founded the Alzheimer’s Drug Discovery Foundation (ADDF) in 1998, they knew that proprietary boundaries would only limit efforts to develop effective Alzheimer’s drugs. So they resolved to make the ADDF’s knowledge available to everyone working to overcome this devastating... Continue Reading

May 05, 2016

Nature Article on Philanthropy in Drug Development Features The Harrington Project for Discovery and Development

For the past decade, venture philanthropists have been working to propel promising therapies and vaccines into the clinic, with some success. Venture philanthropist Bill Gates looks on as a health worker vaccinates a child in Ghana In December 2015, Facebook founder Mark Zuckerberg and his wife Priscilla Chan made a... Continue Reading

May 02, 2016

Allinaire Therapeutics, a New Biotechnology Start-Up, Launches to Combat Lung Diseases

CLEVELAND AND INDIANAPOLIS – May 2, 2016 – BioMotiv, a drug development accelerator associated with the Harrington Project, and Indiana University Research and Technology Corp. announce the formation of a new biotechnology start-up, Allinaire Therapeutics. Allinaire Therapeutics aims to develop novel therapeutics... Continue Reading

April 18, 2016

Arix Bioscience Has Made $25 Million Commitment to Leading Therapeutics Research Accelerator, BioMotiv

LONDON, APRIL 18, 2016: - Arix Bioscience Limited (Arix Bioscience), formerly Perceptive Bioscience Investments Limited, a global healthcare and life science company supporting medical innovation, announced today it has agreed to provide up to $25 million capital to BioMotiv LLC, a US-based therapeutic accelerator organization... Continue Reading

April 13, 2016

Charles River Laboratories and BioMotiv Enter Into Strategic Partnership

WILMINGTON, MA, April 13, 2016 – Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with BioMotiv, LLC, the therapeutic accelerator company associated with The Harrington Project for Discovery & Development. Through this partnership, Charles... Continue Reading